Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 5Leukemia 4Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Neoplasm, Residual 1Leukemia, Myeloid, Accelerated Phase 1Graft vs Host Disease 1

Interventions

Peripheral Blood Stem Cell Transplantation 6fludarabine phosphate 4Methotrexate 4Cyclosporine 4Tacrolimus 3Radiotherapy 3Mycophenolic Acid 3Cyclophosphamide 3Whole-Body Irradiation 2Pentetic Acid 2Busulfan 2ethanolamine oleate 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Transplantation 1Therapeutics 1Sulfamethoxazole 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Pentostatin 1Minocycline 1Methylprednisolone 1Melphalan 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1Idarubicin 1Heparin 1Flow Cytometry 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Leukemia, Myeloid, Accelerated Phase × Idarubicin × Clear all
NCT00004878 2020-07-31

Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

Jonsson Comprehensive Cancer Center

Phase 2 Withdrawn
MyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡